Identifying therapeutic targets requires a detailed analysis of the toxin's interaction with the body. This involves studying the pathophysiology of the toxic response, including the identification of key proteins, receptors, or genes involved in the toxic process. Advanced techniques such as proteomics and genomics play a significant role in this phase. Once targets are identified, researchers can design drugs or biologics that specifically modulate these targets to alleviate toxic effects.
